课题基金 / 基金详情

DOT-HARRT for HIV-Infected South African Adults

DOT-HARRT for HIV-Infected South African Adults
针对感染艾滋病毒的南非成年人的 DOT-HARRT
批准号:
7065441
负责人:
JEAN BISIMWA NACHEGA
金额:
$13.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-15 至 2011-02-28

项目摘要

项目成果

JEAN BISIMWA NACHEGA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The early years of the combination antiretroviral therapy (ART) era have brought about dramatic reductions in the morbidity and mortality associated with HIV infection in industrialized countries and recently, international and local initiatives have allowed access to HAART in the developing world. Preliminary data from my prior work and others have shown that good adherence is feasible in resource-limited settings, but it is unclear whether these results are reproducible in scaled ART programs and what interventions would likely be effective at maximizing adherence in such settings. Peer advocates have been used to improve adherence with medical therapies in a variety of settings. In order to investigate the potential utility of peer advocates in South Africa, I propose to conduct a randomized trial in which 300 patients will be assigned to either peer-DOT-HAART or self-administration of a twice daily combination of Stavudine, Lamivudine and Efavirenz for 24 months. The specific aims of this study are: 1) to evaluate the impact of peer-DOT HAART on control of viral burden and immune restoration as measured by viral load and CD4 T cell counts; 2) to evaluate the impact of DOT-HAART on treatment adherence; 3) the determination of the proportion of genotypic HAART resistance in the peer-DOT vs. self-administered HAART arms; 4) to compare the incidence of new or recurrent opportunistic infection in the peer-DOT vs. self-administered HAART. My hypothesis is that the patients in the peer-DOT-HAART arm will have high levels of treatment adherence and hence more effective in controlling viral burden, thereby limiting the likelihood of virologic failure, drug resistance, and disease progression. This study will generate critical data on an alternative community-based approach of delivering HAART which may become a standard of care throughout sub-Saharan Africa and the developing world. My career development plan is based on a post-graduate training program, which includes comprehensive coursework at the Johns Hopkins University and University of Cape Town, structured mentoring, and guidance from a thesis committee. My career plan and research proposal are consistent with my long-term goals of becoming an effective independent investigator, and optimizing treatment outcomes in HIV-infected in sub-Saharan Africa.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Pittsburgh HIV-Comorbidities Research Training Program in South Africa
University of Pittsburgh HIV-Comorbidities Research Training Program in South Africa
University of Pittsburgh HIV-Comorbidities Research Training Program in South Africa
University of Pittsburgh HIV-Comorbidities Research Training Program in South Africa
国内基金
海外基金
基于FPGA和ARM的高精度智能电力局部放电检测装置开发
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    王伟炳
  • 依托单位:
CD38调控AEC2线粒体功能促进CTD-ILD进展及其CD38-ARM-EVs的靶向干预
  • 批准号:
    JCZRLH202500222
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
ARM重复序列基因PvPUB5可变剪切调控菜豆干旱胁迫响应的分子机制
  • 批准号:
    QN25C150021
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    柯旭波
  • 依托单位:
基于Arm架构的机密计算及关键技术研究
  • 批准号:
    62372218
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    张锋巍
  • 依托单位: